GenomesDAO logo

GenomesDAO (GENE)

Website
TwitterDiscordMore socials
Status
IDO

GenomesDAO is a genomic data security company that democratizes and decentralizes genomics in Healthcare. Users make passive income on their DNA stored in AMD SEV-ES, vaults using DeFi Protocol governance and DAO membership is only achieved by staking GENE, the deflationary GenomesDAO utility token.

GenomesDAO White Paper Whitepaper

Important By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Interest lvl
Medium
Learn more about our rating
User Rating
Medium
3/5 1 votes
Claim your project
Ticker
GENE
Type
Utility-token
FoundedUnited Kingdom
Registration countryUnited Kingdom
Registration year2018
Office address30 Caledonian Road, London, London N1 9DT, GB
Ecosystems

What is GenomesDAO

Genomes.io is a genomic data security company co-founded by Dr Mark Hahnel and Aldo de Pape in 2018. We are a UK-registered company and operate from London, UK. The project strives to meet the increasing expectations of research organizations, institutions as well as customers for the security of genomic data and the quality of research workflow. In order to increase the democratization and decentralization of genomic studies, we focus on combining cutting-edge technologies such as AMD’s SEV, blockchain and decentralized finance.

GenomesDAO Roadmap

1
16th November 2021

MISO Public $GENE Sale

2
2021

NFT Project Launch

3
Q4 2021

Company Operations

  • Scale up Team
  • Apply tokenomics across platform
4
2022

10,000 Genomes is our AMD SEV-ES vaults
Brokerage of Data to pharma - aka - making passive income for our users
Launch of GenomesDAO secure Organisational Platform (Rare Disease Charities etc)
Expansion of Tests Available - Open API to 3rd Parties

Token Sale Dates

IDO

Start date: Nov 16, 2021
End date: Nov 16, 2021

Token Allocation

Total Token Supply 1,000,000,000 GENE
Total Tokens for Sale 300,000,000 GENE

Funding Details

Funds Raised (as of now) 100 ETH

Token distribution


30% - IDO
30% - Liquidity
6% - Pre Seed
5.66% - Folks who supported GenomesDAO over the last 3 years
8.34% - Marketing
10% - Team
10% - Locked

Project team

Aldo De Pape
Aldo De Pape
CEO
Aldo De Pape linkedin-team
Dr. Mark Hahnel
Dr. Mark Hahnel
Chief Scientist
Dr. Mark Hahnel linkedin-team
Micky Socaci
Micky Socaci
Lead Developer
Louis Gooden
Louis Gooden
Analyst
Vlad Morar
Vlad Morar
Software Developer
Krisid Misso
Krisid Misso
Project Manager
Deivis Kuqo
Deivis Kuqo
UX/UI Designer
Xheni Haxhiu
Xheni Haxhiu
Software Developer
Axhem Shahaj
Axhem Shahaj
Software Developer
Calin G
Calin G
Blockchain Developer
Xhuljan Teleku
Xhuljan Teleku
Front-end Developer
Bastian Greshalke
Bastian Greshalke
Lead Bioinformatician

Advisors

Praneeth Srikanti
Praneeth Srikanti
Investment Principle at Consensys Labs
Prof Hugh Montgomerey
Prof Hugh Montgomerey
Director of UCL Institute for Human Health and Performance
Joe Stringer
Joe Stringer
Managing Partner of TenX Health

Social media

Industries

Leave a Reply

Your email address will not be published. Required fields are marked *

listing on exchanges

Leave a Reply

Your email address will not be published. Required fields are marked *

Sponsored Crypto Projects

KYMAi (KYMAI) logo
KYMAi (KYMAI) Sponsored
KYMAi (KYMAI)
Low
ICO
NOCtura (NOC) logo
NOCtura (NOC) Sponsored
NOCtura (NOC)
Low
ICO
Zama (ZAMA) logo
Zama (ZAMA)
High
ICO
IEO

Newly Published